Necrolytic Migratory Erythema as the First Manifestation of Glucagonoma
Open Access
- 27 August 2012
- journal article
- case report
- Published by Hindawi Limited in Case Reports in Surgery
- Vol. 2012, 1-2
- https://doi.org/10.1155/2012/974210
Abstract
Necrolytic migratory erythma (NME) as a rare skin disorder that can affected Perineum, distal extremities, lower abdomen and face are the most commonly affected sites.It can be as a part of Glucagonoma syndrome that is defined as an association of glucagonoma with NME, hyperglucagonemia, glucose intolerance, anemia and weight loss. Here, Authors describe a woman admitted to the dermatology ward with NME which was later found to be associated with glucagonoma and multiple hepatic lesions.Keywords
This publication has 10 references indexed in Scilit:
- The glucagonoma syndrome and necrolytic migratory erythema: a clinical reviewActa Endocrinologica, 2004
- Necrolytic migratory erythema as the only presenting sign of a glucagonomaJournal of the American Academy of Dermatology, 2003
- Duodenal somatostatinoma: A case report and review of 31 cases with special reference to the relationship between tumor size and metastasisPathology International, 2000
- Clinical Spectrum of Hyperglucagonemia Associated With Malignant Neuroendocrine TumorsMayo Clinic Proceedings, 1996
- Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.1986
- Histologic Variation in the Skin Lesions of the Glucagonoma SyndromeThe American Journal of Surgical Pathology, 1986
- A GLUCAGONOMA SYNDROMEThe Lancet, 1974
- Necrolytic Migratory Erythema with Pancreatic CarcinomaProceedings of the Royal Society of Medicine, 1971
- A Glucagon-Secreting Alpha-Cell Carcinoma of the PancreasNew England Journal of Medicine, 1966
- Benign and Malignant Cutaneous Tumors in the ElderlyArchives of Dermatology, 1961